26 May 2013
Keywords: strong, data, gsk, coreg, seen, ash, uk
Article | 29 May 2006
UK drug major and world number two by sales volume GlaxoSmithKline says that its beta-blocker Coreg CR (carvedilol phosphate controlled-release
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
29 May 2006
24 May 2013
© 2013 thepharmaletter.com